Bora Oh

The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib

Kang‐Seo Park, Bora Oh, Mi-Hee Lee et al. · Cancer Letters · 2015 · 41 citations

Intrinsic Resistance, Medicine, Immune Checkpoint Inhibitor +7

Comprehensive characterization of viral integrations and genomic aberrations in HBV‐infected intrahepatic cholangiocarcinomas

Jihyun An, Deokhoon Kim, Bora Oh et al. · Hepatology · 2021 · 28 citations

Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand

Bora Oh, SoJung Park, Jhang Ho Pak et al. · Biochemical and Biophysical Research Communications · 2012 · 17 citations

Breast Oncology, Daunorubicin Pretreatment, Medicine +9

Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination‐deficient hepatocellular carcinoma

Jihyun An, Ji‐Hye Oh, Bora Oh et al. · Hepatology · 2022 · 14 citations

Prognostic Molecular Indices of Resectable Hepatocellular Carcinoma: Implications of S100P for Early Recurrence

Hee Sang Hwang, Jihyun An, Hyo Jeong Kang et al. · Annals of Surgical Oncology · 2021 · 10 citations